When comparing the medium and high-dose NRG-1 antibody groups with the myopia group, the retina and sclera, measured at the posterior pole, equator and ora serrata, were significantly thicker in the medium and high-dose NRG-1 antibody groups than in the myopia group (Figure 3). The gene discussed is NRG1; the disease is myopia.